|
Combining Plasmonic Nanostructures and Machine Learning to Detect and Modulate Protein Aggregation
This innovation is a nanotechnology- and artificial intelligence-powered platform that combines plasmonic gold nanomaterials (AuNMs) with machine learning (ML) to achieve high-throughput, selective, and broad-spectrum identification of potential inhibitors of amyloid beta aggregation. Proof of concept testing found that the platform can identify spectral...
Published: 3/2/2026
|
Inventor(s): Kenry FNU, Célia Sahli
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Neurology, Technology Classifications > Research Tools > Simulators and Modeling Tools, Technology Classifications > Software & Information Technology > Health IT
|
